Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1974 Apr 27;2(5912):193–194. doi: 10.1136/bmj.2.5912.193

Deterioration in Renal Function after Beta-blockade in Patients with Chronic Renal Failure and Hypertension

David J Warren, C P Swainson, N Wright
PMCID: PMC1610826  PMID: 4832235

Abstract

Treatment of hypertension with beta-blocking agents in three patients with moderately severe chronic renal failure was followed by rapid deterioration of renal function. In two of the patients the need for maintenance haemodialysis was accelerated but renal function in the third reverted to pretreatment levels after the drug was stopped. These findings suggest that until more is known about the effects of beta-blocking drugs they should not be given to patients with moderately severe renal failure.

Full text

PDF
194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bufano G., Piacentini L. Studio comparativo dell'influenza esercitata da agonisti e antagonisti beta-adrenergici sulla funzione renale dell'uomo normale. Minerva Med. 1969 Apr 4;60(27):1229–1232. [PubMed] [Google Scholar]
  2. Bühler F. R., Laragh J. H., Baer L., Vaughan E. D., Jr, Brunner H. R. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med. 1972 Dec 14;287(24):1209–1214. doi: 10.1056/NEJM197212142872401. [DOI] [PubMed] [Google Scholar]
  3. Ibsen H., Sederberg-Olsen P. Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci. 1973 Feb;44(2):129–134. doi: 10.1042/cs0440129. [DOI] [PubMed] [Google Scholar]
  4. Lydtin H., Kusus T., Daniel W., Schierl W., Ackenheil M., Kempter H., Lohmöller G., Niklas M., Walter I. Propranolol therapy in essential hypertension. Am Heart J. 1972 May;83(5):589–595. doi: 10.1016/0002-8703(72)90397-3. [DOI] [PubMed] [Google Scholar]
  5. Nayler W. G., McInnes I., Swann J. B., Carson V., Lowe T. E. Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields. Am Heart J. 1967 Feb;73(2):207–216. doi: 10.1016/0002-8703(67)90150-0. [DOI] [PubMed] [Google Scholar]
  6. Prichard B. N., Gillam P. M. Treatment of hypertension with propranolol. Br Med J. 1969 Jan 4;1(5635):7–16. doi: 10.1136/bmj.1.5635.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Schirmeister J., Decot M., Hallauer W., Willmann H. Beta-Receptoren und renale Hämodynamik des Menschen. Arzneimittelforschung. 1966 Jul;16(7):847–850. [PubMed] [Google Scholar]
  8. Sowton E., Balcon R., Cross D., Frick H. Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease. Br Med J. 1968 Jan 27;1(5586):215–216. doi: 10.1136/bmj.1.5586.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Stephen S. A. Unwanted effects of propranolol. Am J Cardiol. 1966 Sep;18(3):463–472. doi: 10.1016/0002-9149(66)90071-3. [DOI] [PubMed] [Google Scholar]
  10. Warren D. J., Ferris T. F. Renin secretion in renal hypertension. Lancet. 1970 Jan 24;1(7639):159–162. doi: 10.1016/s0140-6736(70)90404-6. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES